Jpmorgan Chase & Co »

Viking Therapeutics Inc call shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Viking Therapeutics Inc call shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Viking Therapeutics Inc call

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics Inc call held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics Inc call by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $23M 370k 63.31
2024-06-30 $9.5M 180k 53.01
2024-03-31 $7.7M 94k 82.00
2023-09-30 $664k 60k 11.07
2023-06-30 $2.3M 143k 16.21
2022-12-31 $188k 20k 9.40
2019-03-31 $73k 7.3k 10.00

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Viking Therapeutics Inc call

Group One Trading
Simplex Trading
Jpmorgan Chase & Co
Worth Venture Partners
Advisor Group Holdings

View all funds holding Viking Therapeutics Inc call